SYRE
Spyre Therapeutics Inc.
80.10$
-13.6%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.06 | -1.43 | -0.78 | -1.37 | -0.58 | -0.79 | -0.68 | -0.77 | -0.61 | -0.59 | -0.73 | -0.82 | -2.47 | |
| 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | -0.24 | – | – | – | -0.11 | – | – | – | |
| 1.11 | 0.80 | 0.38 | 0.19 | 0.26 | 0.20 | 0.15 | 0.15 | 0.16 | 0.13 | 0.16 | 0.16 | 0.54 | |
| -1.85 | -0.09 | 0.10 | -0.64 | 0.20 | 0.23 | -0.01 | -0.15 | 0.10 | -0.03 | 0.00 | -0.11 | -0.06 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -22.74 | -1.63 | -2.87 | -2.66 | 0.84 | -3.63 | 0.00 | 1.30 | 0.41 | -3.29 | 0.72 | -3.52 | -5.47 | |
| – | – | 0.00 | 0.00 | – | – | 0.00 | 0.00 | – | 0.00 | – | – | – | |
| – | – | – | – | 0.00 | 0.00 | – | – | – | – | – | – | – | |
| -2.92 | 7.54 | 4.72 | 0.01 | 0.25 | 4.80 | 0.00 | 0.01 | -0.08 | 4.17 | 0.16 | 5.11 | 8.89 | |
| -33.72 | 4.48 | 1.06 | -4.03 | 0.51 | 0.38 | -0.68 | 0.55 | -0.28 | 0.28 | 0.15 | 0.77 | 0.95 | |
| -8.06 | -1.43 | -0.78 | -1.37 | -0.58 | -0.79 | -0.68 | -0.77 | -0.61 | -0.59 | -0.73 | -0.82 | -2.47 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.